COVID-19 nasal vaccine launch: Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday (January 26), official sources said.
According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC庐 (BBV154) as a booster dose in the country.Earlier this month, Bharat Biotech received approval from the Central Drugs Standard Control Organization (CDSCO) for the use of heterologous booster doses of iNCOVACC庐.
The vaccine is still not available on CoWin. According to the statement issued by the company, iNCOVACC庐 i is priced at Rs 800 for private markets and priced at Rs 325 for supplies to the government of India and State Governments."iNCOVACC庐 is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion-stabilized SARS-CoV-2 spike protein. This vaccine candidate was evaluated in phases I, II and III clinical trials with successful results. iNCOVACC庐 has been specifically formulated to allow intranasal delivery through nasal drops. The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries." the statement read.
Dr Krishna Ella, Executive Chairman said; "We have achieved the goals we set for ourselves during this pandemic. We have developed COVAXIN庐 and iNCOVACC庐, two COVID vaccines from two different platforms, with two different delivery systems. The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics. We thank the Ministry of Health, CDSCO, Dept of Biotechnology, Govt of India, Technology Development Board, and Washington University, St Louis, for their support and guidance."
As a needleless vaccination, Bharat Biotech's iNCOVACC庐 will be India's first such booster dose.On the occasion of the launch, the Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh, Dr Krishna Ella, Executive Chairman , Bharat Biotech and Suchitra Ellla, Joint Managing Director, Bharat Biotech will also be present.聽
(With ANI inputs)
ALSO READ: Nasal swab can provide early warning of emerging viruses? Here's what the research says
ALSO READ: Bharat Biotech's nasal vaccine for Covid to cost Rs 800 for private hospitals, Rs 325 for govts